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   ABSTRACT 
  
The 315-residue N-terminal T domain of colicin E3 functions in 
translocation of the colicin across the outer membrane through its 
interaction with outer membrane proteins including the OmpF porin. The 
first 83 residues of the T domain are known from structure studies to be 
disordered. This flexible translocation subdomain contains the TolB box 
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(residues 34 to 46) that must cross the outer membrane in an early 
translocation event, allowing the colicin to bind to the TolB protein in the 
periplasm. In the present study, it was found that cytotoxicity of the 
colicin requires a minimum length of 19 to 23 residues between the C 
terminus (residue 46) of the TolB box and the end of the flexible 
subdomain (residue 83). Colicin E3 molecules of sufficient length display 
normal binding to TolB and occlusion of OmpF channels in vitro. The 
length of the N-terminal subdomain is critical because it allows the TolB 
box to cross the outer membrane and interact with TolB. It is proposed that the length constraint is a 
consequence of ordered structure in the downstream segment of the T domain (residues 84 to 315) that 
prevents its insertion through the outer membrane via a translocation pore that includes OmpF. 
 









Transport of proteins across membranes in import and secretion is known 
to require an assembly of integral membrane proteins that provides 
passage across the hydrophobic membrane (29, 36). Such an assembly is 
utilized by colicins, which parasitize receptors in the outer membrane to 
gain entry into the cell (8, 27, 28, 46). Colicins are highly specific in that 
they kill only those cells that (i) contain the receptor protein to which 
colicin binds and (ii) do not produce the cognate immunity protein, 
providing a selective advantage to the colicin-producing cell in a competitive environment (37). 
Colicin production is under SOS control, forming part of the stress response of the cell (20, 43). Colicins 
are produced in complex with a small (molecular mass of 10 kDa) immunity protein that protects the 
cell from both exogenous and endogenous colicins (7, 22). Colicins have been divided into two groups 
based on the protein translocation network utilized to cross the outer membrane. Group A colicins, such 
as the E colicins, utilize the Tol system, consisting of TolA, TolB, TolQ, TolR, and Pal proteins (15, 28, 
31). Group B colicins, such as colicins B, D, Ia, and Ib, utilize the Ton system consisting of TonB, 
ExbB, and ExbD proteins (8, 16). Colicin E3, a 16S rRNase (5), possesses a domain structure (34, 35, 
41) as found in other colicins (1, 2, 13, 14, 45). It consists of three separate domains that have distinct 
roles. Its 315-residue N-terminal T domain functions in cell translocation and entry (1, 2, 41). The 
central 135-residue receptor (R) domain binds to BtuB (25), and the C-terminal domain contains the 
catalytic activity (34, 35, 41). The first step of E3 entry into the cell involves binding of the R domain to 
BtuB (25), a 22-stranded ß-barrel outer membrane receptor whose metabolic function is transport of 
cyanocobalamin (vitamin B12) across the outer membrane (10, 17, 24). It has been inferred that colicin is 
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translocated across the outer membrane through OmpF (21, 26, 47), a very abundant ( 105 copies/cell) 
(33) outer membrane porin (12, 32), and binds to TolB protein in the periplasmic space (6). However, 
the details of colicin entry through OmpF are largely unknown. The cytotoxicity of colicin E3 is 
dependent on the interaction of the periplasmic TolB protein with the TolB box spanning residues 34 to 
46 (18, 19), which is contained in the 83-residue N-terminal translocation subdomain—the T83 segment. 
It is likely that the high Gly content of this subdomain and its resulting flexibility (11, 41) allow it to 
traverse the outer membrane through a translocation complex that contains OmpF (25, 47) and to 
interact with the TolB protein in the periplasmic space (6). 
The present studies show that the peptide segment (TolB extensor) that separates the C-terminal end of 
the TolB box, residue 46, from the end of the N-terminal flexible subdomain, residue 83, has a minimum 
length. The length of the segment is 37 residues (residue 47 to 83) in the wild-type protein. However, the 
minimum length of this TolB extensor that is required for cytotoxic activity is between 19 and 23 
residues. It is proposed that this length constraint results from the existence of a folded conformational 
state of the downstream region (84 to 315) of the T domain that blocks its transfer across the outer 
membrane through the translocation pore (Fig. 1A and B). 
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FIG. 1. Models for different conformational (folding) states of 
colicin E3 when it binds to, and inserts into, a translocation pore that 
utilizes OmpF. (A) T domain is fully/partially folded when colicin 
interacts with the TolB protein. The immunity protein may or may 
not be bound to colicin E3 when it interacts with TolB protein. In 
this case, the TolB extensor region (37 residues), extending from 
residue 46 to 83, has no extra length, thus causing steric limitations 
reflected in the requirement for a minimum length of the TolB 
extensor. The R domain is depicted to be folded as a coiled coil. (B) 
Colicin/T domain is unfolded when it interacts with TolB. In this 
case, there is extra length in the TolB extensor. The coiled coil of 
the R domain is depicted as partly unfolded. (C) Outer membrane 
BtuB/OmpF translocon for the import of colicin E3. Abbreviations: 
C, catalytic domain; R, receptor binding domain; T, translocation 
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Bacterial strains, media, and plasmids. 
Escherichia coli XL1-Blue strain was used 
as the host strain for cloning of mutations 
and deletions. All cloning was done in the 
pET41b vector, with the colicin constructs 
containing a His8 tag at the C terminus of 
the immunity protein. E. coli BL21(DE3) 
was the host strain for the expression vector pET41b. In the pET41b vector, protein expression is under 
the control of a strong isopropyl-ß-D-thiogalactopyranoside (IPTG)-inducible T7 RNA polymerase 
promoter. All cultures were grown in LB media or on LB agar plates supplemented with antibiotic when 
required. 
Mutagenesis and protein purification. All cloning and mutagenesis was done using standard protocols. 
Colicin E3 was first amplified using upstream (Nde primer) and downstream (Xho primer) primers and 
then cloned between the NdeI-XhoI sites of the expression vector pET41b, so that ImmE3 contained a C-
terminal polyhistidine tag to facilitate protein purification (pWC41E3). All mutagenesis experiments 
were carried out using this construct by an overlap two-step PCR method (38). The first and second PCR 
were set up, respectively, using (i) the mutation containing primers and the corresponding upstream 
(Nde) or downstream (Xho) primer or (ii) the Nde/Xho primers and the purified products of the first 
PCR as the template. This PCR product was then digested with NdeI-XhoI and cloned in pET41b. All 
constructs contained a C-terminal His8 tag on ImmE3. Purification of overexpressed colicin E3 
constructs was carried out with a Ni-charged iminodiacetic acid-agarose column. The colicin E3 deletion 
constructs generated for the present study are E3 65-73 and E3 72-80, with 9 residues deleted; a 14-
residue deletion construct, E3 65-78; and E3 65-83, with 19 residues missing from the TolB extensor 
region. Further, E3 60-64/ 65-78, with 14 residues deleted and residues 60 to 64 mutated (S60A, G61S, 
H62A, G63S, N64A) was created. Also, 5 residues were added to E3 65-83 to generate the construct 
E3 79-83/ 65-78 which can also be considered a construct with 65 to 78 residues deleted and residues 
79 to 83 mutated (G79S, N80A, L81A, S82A, A83S). 
Plasmid pRJ379 containing C-terminally His-tagged TolB in the pET21d vector (9) was a generous gift 
from R. James and was used for the overexpression and purification of TolB. Purification of TolB was 
done by metal affinity chromatography using an Ni-charged iminodiacetic acid-agarose column. 
Cytotoxicity. Cytotoxicity of the different colicin E3 constructs was determined by analyzing the effect 
of colicin constructs on the growth rate of colicin-sensitive E. coli K17 indicator cells. One hundred 
milliliters of LB media was inoculated with an overnight culture of the indicator cells and grown to an 
OD600 (optical density at 600 nm) of 0.1. The culture was then aliquoted, and a different colicin 
construct was added to each sample at a concentration of 3.2 nM. Cell growth was monitored by 
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measuring the OD600 at 1-h intervals. 
Cytotoxicity of the E3 constructs was also compared by analysis of colony-forming ability. E. coli K17 
cells were grown at 37°C under aerobic shaking conditions to an OD600 of 0.1, when 3.2 nM colicin was 
added. Cells were incubated for 1 h and then diluted and transferred to LB agar plates, from which the 
relative colony-forming ability was measured. The effective multiplicity (m) was calculated from the 
relative colony-forming ability that resulted from the cytotoxic action of each colicin construct, 
assuming exponential loss of the surviving cell population (S) relative to the untreated control cells (So) 
as a function of added colicin (i.e., S/So = e–
m). It is recognized that cell survival is not truly an 
exponential process at low levels of cell survival. Thus, the multiplicity, m, is used as a qualitative 
measure of activity of the different constructs. 
TolB binding. TolB binding to the various colicin constructs was analyzed by gel filtration 
chromatography, using the different elution patterns of E3 and TolB proteins on a Superdex 75 column 
(total column volume = 23.6 ml). Each colicin construct was mixed with TolB protein in a 1:1 molar 
ratio (18 µM), and the binding reaction was allowed to proceed for 10 min. This was followed by 
separation on the Superdex 75 column and determination of the protein peaks in the elution profile. The 
total protein in each peak, represented by the area under that peak, was calculated for each colicin 
construct. 
Occlusion of OmpF. The E3 constructs were used to study occlusion of OmpF channels incorporated 
into planar bilayers as described previously (47). The synthetic phospholipids DOPC and DOPE were 
mixed in a 1:1 molar (total concentration, 10 mg/ml) ratio, dissolved in n-decane, and then used to form 
planar bilayers (4, 42). Bilayers were formed by painting lipids using a brush technique (30) on a 0.45-
mm aperture in a partition separating two 1-ml chambers containing 10 mM HEPES (pH 7.0), 0.1 M 
KCl at 23°C. Occlusion was studied by measuring the current across this aperture with Ag/AgCl 
electrodes which are immersed into the two chambers, using a Warner BC-525C amplifier (Hamden, 
CT). To form channels, OmpF (1 pg/ml to 1 ng/ml) was added to the cis side of the membrane, and the 
solution was stirred until channels appeared. A transmembrane potential was applied to the cis side, with 
the trans side at electrical ground. A final concentration of 0.5 to 1 µg/ml of the colicin construct whose 
occlusion activity was to be tested was added to the trans or cis side of the aperture. 
 
   RESULTS 
  
TolB binding. To specifically study the role of the length of the TolB 
extensor region (segment 47 to 83) in colicin cytotoxicity, it was 
http://jb.asm.org/cgi/content/full/189/2/363?maxtosh...TINDEX=0&volume=189&firstpage=363&resourcetype=HWCIT (5 of 15)3/26/2007 3:10:18 PM








necessary to make deletions that would not affect the affinity of colicin 
E3 for TolB. Otherwise, any decrease in cytotoxicity might be 
ambiguous, as it would include effects of both length and TolB binding 
affinity. Therefore, deletions in the TolB extensor were made as far 
downstream from the TolB box as possible. A colicin construct was first 
allowed to interact with TolB, following which the complex was 
separated on a Superdex 75 column. The peak fractions of colicin E3 (and 
constructs) and TolB protein appeared, respectively, at elution volumes of 
8.2 ± 0.3 ml and 11.0 ± 0.1 ml. The colicin/TolB complex eluted at a volume of 8.0 ± 0.35 ml. Because 
the peak of the colicin-TolB complex overlapped that of the colicin alone, the amount of free TolB (area 
under of curve of TolB elution peak) was used to measure the TolB binding affinity of the colicin. 
Deletion of 14 ( 65-78) or 19 ( 65-83) residues from the TolB extensor region did not affect binding to 
TolB. Two additional constructs were tested that were important in the cytotoxicity studies (see below). 
Mutation of 5 residues, N- and C-terminal to the 65-78 deletion, in the two mutants, E3 60-64/ 65-78 
and E3 79-83/ 65-78, did not affect binding to TolB. All of the deletion constructs except E3 43-52 
displayed wild-type affinity for TolB (Fig. 2). There was almost no binding of E3 43-52 to TolB, 
which is expected, as this construct lacks the complete TolB box that spans residues 34 to 46 (19). The 
Trp39Ala (W39A) mutant was a negative control, as modifications of the TolB box prevent binding to 
TolB (9). Studies on the question of a critical length of the N-terminal domain were confined to the 
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FIG. 2. TolB binding affinity of colicin constructs 
measured by the area under the elution peaks formed by 
colicin/TolB complex separated on a Superdex 75 
column, as described in Materials and Methods. The 
affinity is normalized to the total amount of TolB added 
(1.0 on the ordinate). 
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Cytotoxicity. Cytotoxicity, used as an indicator of the relative activity of the constructs obtained from 
mutations in the colicin N-terminal subdomain, was assayed through the effect of colicin on the growth 
of sensitive cells (Fig. 3A and B) and the relative colony forming ability (Fig. 3C). Growth curves of 
wild-type cells to which no colicin or colicin E3 (3.2 nM) was added are compared (Fig. 3A). Deletion 
of 29 residues (E3 55-83) or 19 residues (E3 65-83) abolished cytotoxicity so that the growth curve 
was the same as the control to which no colicin was added (Fig. 3A). However, deletion of 9 residues 
(E3 65-73 and E3 72-80) at either of the two positions in the extensor region had a negligible effect 
on colicin cytotoxicity (Fig. 3A). Increasing the length of the deletion to 14 residues (E3 65-78) 
resulted in a small decrease ( 7% decrease in the calculated multiplicity, m) in cytotoxicity compared to 
the wild-type colicin, as shown in the comparison of growth curve inhibition (Fig. 3B) and the effective 
multiplicities (Fig. 3C). Addition of 5 residues to the 19 residue deletion construct E3 65-83, to 
generate a 14 residue deletion construct E3 79-83/ 65-78, restored essentially all activity compared with 
E3 65-78, which also has 14 residues deleted in the TolB extensor region (Fig. 3B and C). The 5 
residues (Ser, Ala, Ala, Ala, Ser), added to the C-terminal end of the 65-83 deletion, are different from 
the residues present in the wild-type E3 (Gly, Asn, Leu, Ser, Ala). Thus, because deleting 19 residues 
from the 37-residue extensor abolishes all activity and removal of 14 residues allows almost full 
cytotoxicity, the minimum length of the TolB extensor is 19 to 23 residues. Deletions that further shorten 
this segment abolish colicin cytotoxicity. 
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FIG. 3. Effect of the various colicin constructs on the growth of E. 
coli K17 indicator cells. (A) Colicins were added at a concentration 
of 3.2 nM. E3 55-83, E3 65-83, and E3 43-52 did not inhibit 
cell growth, while E3 65-73 and E3 72-80 were as active as wild-
type E3. (B) E3 65-78 and E3 79-83/ 65-78 had a similar activity, 
which was slightly less than that of wild-type E3. E3 60-64/ 65-78 
showed decreased cytotoxicity compared to E3 65-78. Error bars 
are contained within symbols if they are not explicitly displayed. (C) 
Effective multiplicity of colicin and constructs that inhibited cell 
growth in panel B. *, The m value and fractional survival for E3 
65-83 have been assumed to be similar to the control in which no 
colicin was added on the basis of their identical growth curves and is 
shown here for purposes of comparison. 
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OmpF binding site. A binding site for OmpF has been proposed in the region 60 to 80 of colicin E9 
(21). No such binding site was found between residues 65 to 83 of colicin E3 because deletions or 
mutations in this region did not affect colicin cytotoxicity. However, when residues 60 to 64 were 
mutated (S60A, G61S, H62A, G63S, N64A) in the construct E3 60-64/ 65-78, there was a decrease of 
40% in the effective multiplicity, m, compared to colicin E3 65-78 and E3 79-83/ 65-78 (Fig. 3B 
and C). Thus, it cannot be excluded that residues 60 to 64 could participate in binding to OmpF. 
Occlusion of OmpF channels. To further characterize the role of residues 60 to 80, E3 deletion 
constructs were also tested for their ability to occlude ion channels of OmpF porin incorporated in planar 
bilayer membranes. Previously, it has been shown that colicin E3 (but not E1), added from the trans side 
of the membrane, is able to specifically occlude OmpF channels on application of cis-negative 
transmembrane potential (47). The occlusion effect was negated when the transmembrane potential was 
changed to cis positive. Residues 5 and/or 7 were shown to be essential for occlusion of OmpF (47), and 
the colicin-OmpF interaction is almost abolished (reduced by 85%) when the first 7 residues are deleted 
(21). The ability of the different E3 constructs to occlude OmpF is summarized in Fig. 4C. E3 55-83, 
in which most of the TolB extensor is deleted, was able to occlude OmpF when added from the trans 
side but not from the cis side (Fig. 4), as was observed for wild-type E3. Thus, the interaction of residues 
60 to 80 with OmpF is weak or negligible. The occlusion of OmpF is dependent on residues 5 and/or 7, 
near the N terminus of the 83-residue translocation subdomain, rather than those in the segment of 
residues 60 to 80 near its C terminus. 
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FIG. 4. E3 55-83 occludes OmpF channels in planar bilayers. 
OmpF was added to the cis side of the membrane and the solution 
stirred until channels appeared. The transmembrane current was 
recorded upon application of transmembrane potentials, 50mV and –
50mV (sign of the potential is that of cis side). (A) E3 55-83 was 
added to the cis side, and no occlusion was seen upon application of 
potential. (B) When the colicin was added from the trans side, it 
occluded OmpF channels upon application of a cis-negative 
potential. The occlusion effect was negated upon changing the 
potential to cis positive. (C) OmpF occlusion by colicin E3 deletion 
constructs. 1, The presence (+) or absence (–) of occlusion denotes 
the ability of 0.5 to 1 µg/ml of colicin to block OmpF ion channels. 
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Formation of the E3/BtuB/OmpF/TolB translocon. The peripheral 
nature of binding of the R domain of colicin E3 to BtuB seen in the X-ray 
structure of the complex (25), as well as the absence of channels formed 
by BtuB in planar bilayers in the presence or absence of colicin (47), 
precludes the possibility of colicin entry through any hypothetical pore of 
BtuB. Thus, a secondary receptor, including OmpF and perhaps other 
outer membrane proteins such as the OmpC porin (32), is needed through 
which colicin can cross the outer membrane. Genetic evidence exists for a role of OmpF in a translocon 
for colicin import across the outer membrane (3). OmpF is abundant in the outer membrane ( 105 copies/
cell), and occlusion of OmpF channels incorporated in planar bilayers with colicin E3 has been well 
characterized (47). The existence of a colicin translocon involving the BtuB receptor, the bound colicin, 
and OmpF or an OmpF cluster has been postulated (21, 25, 47). 
Minimum length requirement of the TolB extensor. The T and R domains of nuclease colicins E2, 
E3, E6, E7, and E9 are highly conserved (39), suggesting that they use similar mechanisms to import C 
domains with different nuclease activities. The nearly identical N-terminal 83-residue subdomain of 
these colicins (39) is remarkable in that it is highly flexible due to the large number of glycines ( 40% of 
residues are Gly) and contains the residues required for interaction with the Tol system. It has been 
proposed that flexibility of the N-terminal region enables it to cross the outer membrane and interact 
with the Tol system in the periplasm (11, 44). It has been found in the present study that a critical aspect 
for such an interaction, along with the flexibility, is the length of the peptide segment separating the Tol 
recognition sequence from rest of the colicin. The requirement of a minimum length of this TolB 
extensor in colicin E3 was determined from the properties of mutations/deletions in the 60- to 80-residue 
region downstream and distal to the TolB box. Binding to TolB was assessed to ensure that deletions in 
this region do not affect interaction with TolB. Experiments with E3 deletion constructs show that 
although deletions of 9 and 14 residues did not affect cytotoxicity, deletion of 19 residues in this region 
causes loss of cytotoxic function. When 5 residues are added back to the 19 residue deletion construct, 
the colicin regains its cytotoxicity, suggesting that length, rather than details of the sequence, in this 
region is the critical parameter. It has been shown in a previous study that a deletion construct E9 60-
80 (a 21-residue deletion) did not bind to OmpF and was inactive, suggesting a second binding site for 
OmpF (21) in addition to an N-terminal site that includes residues 5 and/or 7 (47). However, the role of 
residues 60 to 80 in binding to OmpF is not clear. According to Housden et al. (21), this region is 
responsible for only about 15% of the colicin-OmpF interaction, with residues 1 to 7 being responsible 
for the remaining 85%, with deletions between residues 7 and 53 having a negligible effect on the 
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colicin-OmpF binding. Furthermore, we have shown that deletions/mutations in the entire 60- to 80-
residue region had no effect on occlusion of OmpF by colicin E3 in planar bilayer experiments. In light 
of the above results, it is concluded that the loss of cytotoxicity of E9 60-80 arises from the length of 
the deletion rather than deletion of a putative OmpF binding site. Mutation of residues 60 to 64 caused a 
somewhat decreased cytotoxicity, reflected in a decrease of the effective multiplicity from 14 to 7.4 
(Fig. 3B and C), suggesting that these residues could participate in a weak binding to OmpF. An ordered 
or partially folded structure of the C-terminal segment (residues 84 to 315) of the translocation domain 
could explain the minimum length requirement of the subdomain found in the present study (Fig. 1A and 
B). An ordered T domain can result in a steric constraint on its insertion into the OmpF translocation 
pore and a length restriction in the TolB extensor region. The minimum length of the TolB extensor was 
determined to be between 19 and 23 residues. 
Function of the downstream T domain: mechanism of unfolding. The limiting size of a channel 
through OmpF is 7 by 11 Å (12, 23), which could, in principle, allow for the threading of an unfolded 
polypeptide but not a folded protein. The present studies indicate that at least 60 residues of the N-
terminal subdomain are able to insert through the OmpF complex to contact TolB in the periplasmic 
space. It is inferred that at some distance downstream of this inserted segment, there is an ordered 
structure in the T domain that prevents further insertion of the colicin. This leads to the following 
questions. (i) What is the location of this first folded domain in the T-domain? (ii) What is the function 
of the remaining downstream T domain, spanning residues 84 to 315, which seems not to be required for 
the initial insertion into the receptor? (iii) What is the mechanism of, and energy source for, unfolding of 
the colicin, especially of the C domain whose entry into the cell is absolutely required for cytotoxicity? 
Events in colicin import across the outer membrane. It is not known whether the whole colicin or 
only the C domain of colicin E3 enters the cell. There is evidence that a proteolytic cleavage takes place 
between the R and C domains of colicin E7 during its entry into the cell (40). If such an event also 
occurs in colicin E3, as might reasonably be inferred, the C domain would be the only part of the colicin 
entering the cell. 
In conclusion, the events believed to occur in colicin E3 import through the outer membrane BtuB/
OmpF (and perhaps OmpC) translocon are summarized (Fig. 1C) as follows: colicin binds to BtuB; 
OmpF is recruited into the translocon through interaction of the T domain N terminus with OmpF; 
interaction of T83 with TolB in the periplasm; unfolding of the C-domain and its insertion into an OmpF 
channel (48); proteolytic cleavage of colicin between the C and R domains, allowing entry of the C 
domain into the cytoplasm, where it acts cytotoxically as an endoribonuclease. 
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